Abstract |
|
Authors | Alan Pourpak, Terry H Landowski, Robert T Dorr |
Journal | The Journal of pharmacology and experimental therapeutics
(J Pharmacol Exp Ther)
Vol. 321
Issue 3
Pg. 1109-17
(Jun 2007)
ISSN: 0022-3565 [Print] United States |
PMID | 17351106
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Antineoplastic Agents
- DNA, Catenated
- DNA, Kinetoplast
- DNA-Binding Proteins
- Isoquinolines
- Naphthalimides
- Quinoxalines
- Taxoids
- Topoisomerase II Inhibitors
- XK 469
- Docetaxel
- Mitoxantrone
- DNA Topoisomerases, Type II
- 2-(2'-(dimethylamino)ethyl)-1,2-dihydro-7-ethoxydibenz(de,h)isoquinoline-1,3-dione
- Melphalan
|
Topics |
- Animals
- Antigens, Neoplasm
(genetics, metabolism)
- Antineoplastic Agents
(pharmacology)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- DNA Breaks, Double-Stranded
(drug effects)
- DNA Topoisomerases, Type II
(genetics, metabolism)
- DNA, Catenated
(metabolism)
- DNA, Kinetoplast
(metabolism)
- DNA-Binding Proteins
(antagonists & inhibitors, genetics, metabolism)
- Docetaxel
- Humans
- Isoquinolines
(pharmacology, therapeutic use)
- Male
- Melphalan
(pharmacology)
- Mice
- Mice, SCID
- Mitoxantrone
(pharmacology)
- Naphthalimides
(pharmacology)
- Prostatic Neoplasms
(metabolism, pathology, prevention & control)
- Protein Binding
(drug effects)
- Quinoxalines
(pharmacology)
- RNA Interference
- Taxoids
(pharmacology)
- Topoisomerase II Inhibitors
- Xenograft Model Antitumor Assays
|